Anti-PTBP2 antibody [EPR9890]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal PTBP2 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Rat, Mouse samples. Cited in 7 publications.
View Alternative Names
NPTB, PTB, PTBLP, PTBP2, Polypyrimidine tract-binding protein 2, Neural polypyrimidine tract-binding protein, Neurally-enriched homolog of PTB, PTB-like protein
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PTBP2 antibody [EPR9890] (AB154787)
Immunohistochemical analysis of paraffin-embedded Human glioma tissue labeling PTBP2 with ab154787 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PTBP2 antibody [EPR9890] (AB154787)
Immunofluorescent analysis of HeLa cells labeling PTBP2 with ab154787 at 1/250 dilution.
- WB
Unknown
Western blot - Anti-PTBP2 antibody [EPR9890] (AB154787)
All lanes:
Western blot - Anti-PTBP2 antibody [EPR9890] (ab154787) at 1/1000 dilution
Lane 1:
C6 cell lysate at 10 µg
Lane 2:
Neuro-2a cell lysate at 10 µg
Lane 3:
SH-SY5Y cell lysate at 10 µg
Lane 4:
Y79 (Human retinoblastoma cell line) cell lysate at 10 µg
Lane 5:
HeLa cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 57 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PTBP2 influences various neural functions by modulating the splicing of target RNA transcripts. It contributes to the dynamic regulation of splicing events during neurogenesis and neural development forming part of splicing regulatory networks. PTBP2 does not function as part of a larger protein complex but interacts directly with RNA substrates impacting their stability and translation efficiency. This protein is essential for specific splicing events necessary for neurodevelopmental transitions.
Pathways
PTBP2 affects neural development and differentiation through pathways like axon guidance and synaptic transmission. Its role in alternative splicing enables the proper expression of proteins involved in these pathways such as NRG1 and DSCAM. PTBP2 works closely with related splicing proteins and RNA-binding proteins coordinating the production of specific protein isoforms required for neuronal circuit formation and maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
iScience 26:108258 PubMed38026174
2023
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 9:eadi0286 PubMed37506203
2023
Applications
Unspecified application
Species
Unspecified reactive species
RNA (New York, N.Y.) 28:523-540 PubMed35082143
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells 10: PubMed34944075
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 12:752495 PubMed34707642
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 11:79-90 PubMed29858092
2018
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 29:1113-23 PubMed25466893
2014
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com